NR4A1 and breast carcinoma: A panel of 19 MiralysTM antibody probes was used to stain an FFPE breast cancer tumor tissue section which was obtained commercially, and pathologist assessed as adenocarcinoma of breast (ductal), TNM staging pT2pN0pMX, hormone receptor negative and HER positive (OriGene, Rockville, MD).